Incidence of hidradenitis suppurativa in the United States: A sex- and age-adjusted population analysis

    loading  Checking for direct PDF access through Ovid



The true incidence of hidradenitis suppurativa (HS) is unknown.


To determine standardized incidence estimates for HS in the United States.


We used a retrospective cohort analysis, including incident HS cases identified using electronic health records data for a demographically heterogeneous population-based sample of >48 million unique patients across all 4 census regions. We calculated standardized 1- and 10-year cumulative incidences for the overall population and for sex-, age-, and race-specific groups.


There were 5410 new HS diagnoses over a 1-year period, with an incidence of 11.4 (95% confidence interval [CI], 11.1-11.8) cases per 100,000 population. One-year incidence in women was 16.1 (95% CI, 15.5-16.6) per 100,000, more than twice that of men [6.8 (95% CI, 6.5-7.2) per 100,000; P < .0001]. Age group–specific incidence was highest among patients 18 to 29 years of age [22.0 (95% CI, 21.0-23.2) per 100,000]. Incidence among African Americans [30.6 (95% CI, 29.1-32.2) per 100,000] was >2.5 times that of whites [11.7 (95% CI, 11.3-12.2) per 100,000; P < .0001]. The average annual overall incidence over 10 years was 8.6 (95% CI, 8.6-8.7) per 100,000 population.


The use of deidentified claims prevented validation for a larger case subset.


HS incidence has increased over the past decade and disproportionately involves women, young adults, and African Americans.

Related Topics

    loading  Loading Related Articles